Search Results 501-510 of 18436 for prednisone

1. A Study for the Treatment of Primary Obesity - Mayo Clinic

   Immunosuppressive medications or systemic steroids (i.e., oral prednisone) within 6 months of Visit 1. Intranasal/inhaled steroids are acceptable. Unable or ...

2. Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) - Mayo Clinic

   Systemic treatment with corticosteroids (>10 mg daily prednisone equivalents). Note: Short-course systemic corticosteroids (eg, prevention/treatment for ...

3. Clinical Trials - AUTO1 in Relapsed or Refractory B-ALL

   Steroids: Therapeutic doses of corticosteroids (greater than 10 mg daily of prednisone or its equivalent) within 7 days of leukapheresis or 72 hours prior to ...

4. Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma - Mayo Clinic

   ... prednisone in treating patients with peripheral T-cell lymphoma. Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for ...

5. A Study to Evaluate Posaconazole to Treat Genetically-defined Patients with Active Crohn's Disease - Mayo Clinic

   Subjects receiving oral corticosteroids may continue their use during the study provided the dose (prednisone up to 20 mg/day, budesonide up to 9 mg/day) ...

6. Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) - Mayo Clinic

   ... prednisone 10 mg daily or less, or bioequivalent dose of other corticosteroid):. Temporary steroid use for computed tomography (CT) imaging in setting of ...

7. A Study Of CNTO 136 (Sirukumab), A Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, In Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) - Mayo Clinic

   If using oral corticosteroids, must be on a stable dose equivalent to less than or equal to 10 mg/day of prednisone for at least 2 weeks prior to the first ...

8. Cutaneous T-cell lymphoma - Diagnosis and treatment - Mayo Clinic

   Learn about this type of non-Hodgkin lymphoma that attacks the skin. Find out about symptoms, diagnosis and treatments.

9. Care options for patients with rib fracture - Mayo Clinic

   Trauma professionals have encountered increasing numbers of rib fractures in recent years. Review care for rib fractures, current thinking related to pain ...

10. Clinical trials - Oncology (Medical)

    ... prednisone in treating patients with peripheral T-cell lymphoma. Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for ...